Marlana M. Orloff, MD

home / contributors / marlana-m-orloff-md

Articles

Marlana M. Orloff, MD, an expert on uveal melanoma

Advice for Patients Diagnosed with Metastatic Uveal Melanoma

Marlana M. Orloff, MD
June 2nd 2023

Marlana M. Orloff, MD, offers advice for patients who are diagnosed with metastatic uveal melanoma.

Read More

Marlana M. Orloff, MD, an expert on uveal melanoma

Tebentafusp Treatment Protocol in Metastatic Uveal Melanoma

Marlana M. Orloff, MD
June 2nd 2023

An expert on uveal melanoma reviews the treatment protocol for tebentafusp, which is approved for the treatment of metastatic disease.

Read More

Marlana M. Orloff, MD, an expert on uveal melanoma

Efficacy and Safety of Tebentafusp in the Treatment of Metastatic Uveal Melanoma

Marlana M. Orloff, MD
June 2nd 2023

Marlana M. Orloff, MD, discusses key efficacy data and reviews adverse events seen with tebentafusp in patients with metastatic uveal melanoma.

Read More

Marlana M. Orloff, MD, an expert on uveal melanoma

The Metastatic Uveal Melanoma Treatment Landscape

Marlana M. Orloff, MD
June 2nd 2023

Dr Marlana M. Orloff provides an overview of the treatment landscape for metastatic uveal melanoma.

Read More

Marlana M. Orloff, MD, an expert on uveal melanoma

Diagnosis and Prognosis of Uveal Melanoma

Marlana M. Orloff, MD
June 2nd 2023

An expert on uveal melanoma discusses the presentation, diagnosis, and prognosis of the disease.

Read More

Marlana M. Orloff, MD, an expert on uveal melanoma

Overview of Uveal Melanoma

Marlana M. Orloff, MD
June 2nd 2023

Marlana M. Orloff, MD, gives a brief overview of uveal melanoma, including its incidence and risk factors.

Read More

Latest Updated Articles

The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma: © stock.adobe.com.
Published: April 24th 2025 | Updated: April 26th 2025
FDA Approves Penpulimab-kcqx For Nasopharyngeal Carcinoma
People can help EBCI reach their goal of $20,000 dollars raised for GiveBIG 2025 by giving at endbraincancer.org/donate: © stock.adobe.com.
Published: April 22nd 2025 | Updated: April 26th 2025
Support Patient Access and Education with the End Brain Cancer Initiative for GiveBIG 2025
The End Brain Cancer Initiative is currently seeking Primary Central Nervous System Lymphoma patients and care partners to participate in an online roundtable discussion: © stock.adobe.com.
Published: March 3rd 2025 | Updated: April 26th 2025
Primary Central Nervous System Lymphoma Patient and Care Partner Roundtable Hosted by the End Brain Cancer Initiative
Registration is now open for the 2025 Know All Your Treatment Options (KAYTO25) online patient disease education event/webinar: © stock.adobe.com.
Published: March 17th 2025 | Updated: April 26th 2025
Registration Open for the 2025 Know All Your Treatment Options Webinar Hosted by the End Brain Cancer Initiative
Each May, for over a decade, the End Brain Cancer Initiative (EBCI) has presented the National HOPE Award to a brain cancer patient who deeply inspires us: © stock.adobe.com.
Published: March 18th 2025 | Updated: April 26th 2025
Nominations Open for the End Brain Cancer Initiative’s 2025 National Patient Disease Education Initiative and HOPE Award
Illustration of bladder.
Published: April 22nd 2025 | Updated: April 26th 2025
Imfinzi Combination Shows Efficacy in Bladder Cancer Treatment